These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 30125689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M, Ciccacci F, Andreotti M, Hassane A, Sidumo Z, Magid NA, Sotomane H, David M, Mutemba E, Cebola J, Mugunhe RJ, Riccardi F, Marazzi MC, Giuliano M, Palombi L, Mancinelli S.
    Clin Infect Dis; 2017 Nov 13; 65(11):1878-1883. PubMed ID: 29020319
    [Abstract] [Full Text] [Related]

  • 8. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.
    Esmail A, Pooran A, Sabur NF, Fadul M, Brar MS, Oelofse S, Tomasicchio M, Dheda K.
    J Clin Microbiol; 2020 Sep 22; 58(10):. PubMed ID: 32727831
    [Abstract] [Full Text] [Related]

  • 9. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
    Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, Kosloff B, Ayles H, Atadzhanov M, Dheda K, Koralnik IJ.
    J Clin Microbiol; 2019 Aug 22; 57(8):. PubMed ID: 31189584
    [Abstract] [Full Text] [Related]

  • 10. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, Manabe YC, Dorman SE.
    AIDS; 2014 Jun 01; 28(9):1307-14. PubMed ID: 24637544
    [Abstract] [Full Text] [Related]

  • 11. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H, Ferlazzo G, Bevilacqua P, Kirubi B, Ardizzoni E, Wanjala S, Sitienei J, Bonnet M.
    PLoS One; 2017 Jun 01; 12(1):e0170976. PubMed ID: 28125693
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H, Mathabire Rucker SC, Cossa L, Bastard M, Amoros I, Manhiça I, Mbendera K, Telnov A, Szumilin E, Sanchez-Padilla E, Molfino L.
    PLoS Med; 2019 Apr 01; 16(4):e1002792. PubMed ID: 31039161
    [Abstract] [Full Text] [Related]

  • 13. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
    Kebede W, Abebe G, Gudina EK, Van Rie A.
    Sci Rep; 2021 Dec 24; 11(1):24428. PubMed ID: 34952913
    [Abstract] [Full Text] [Related]

  • 14. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.
    PLoS One; 2015 Dec 24; 10(7):e0133756. PubMed ID: 26222142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A.
    Am J Respir Crit Care Med; 2019 Mar 01; 199(5):643-650. PubMed ID: 30192649
    [Abstract] [Full Text] [Related]

  • 17. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT, Sturegård E, Winqvist N, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, Schön T, Björkman P.
    PLoS One; 2014 Mar 01; 9(1):e85478. PubMed ID: 24465572
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD, Kerkhoff AD, Vogt M, Wood R.
    Lancet Infect Dis; 2012 Mar 01; 12(3):201-9. PubMed ID: 22015305
    [Abstract] [Full Text] [Related]

  • 19. Complementary Nonsputum Diagnostic Testing for Tuberculosis in People with HIV Using Oral Swab PCR and Urine Lipoarabinomannan Detection.
    Shapiro AE, Olson AM, Kidoguchi L, Niu X, Ngcobo Z, Magcaba ZP, Ngwane MW, Whitman GR, Weigel KM, Wood RC, Wilson DPK, Drain PK, Cangelosi GA.
    J Clin Microbiol; 2022 Aug 17; 60(8):e0043122. PubMed ID: 35913145
    [Abstract] [Full Text] [Related]

  • 20. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).
    Mangu C, Cossa M, Ndege R, Khosa C, Leukes V, de la Torre-Pérez L, Machiana A, Kivuma B, Mnzava D, Zachariah C, Manjate P, Tagliani E, Schacht C, Buech J, Singh S, Ehrlich J, Riess F, Sanz S, Kranzer K, Cox H, Sabi I, Nguenha D, Meggi B, Weisser M, Ntinginya N, Schumacher S, Ruhwald M, Penn-Nicholson A, Garcia-Basteiro AL, TB-CAPT Consortium.
    BMC Infect Dis; 2024 Aug 15; 24(1):831. PubMed ID: 39148008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.